ZenoWell vagus nerve stimulation for women’s wellness

Throughout life, women are constantly dealing with hormonal changes. Monthly menstrual cycles, postpartum, and the long transition around menopause all leave a mark on both body and mind. Poor sleep, high stress, anxiety, mood swings, fatigue, and of course, the all‑too‑familiar menstrual pain—these are not just “in your head”.

These experiences are not only about hormones. Increasingly, research shows they are closely linked with the autonomic nervous system—especially the balance between the sympathetic nervous system (our “fight‑or‑flight” mode) and the vagus‑driven parasympathetic system (our “rest‑and‑restore” mode). You can think of them as the body’s “gas pedal” and “brake”. One key concept here is vagal tone: the healthier it is, the more easily we can switch between stress and relaxation. Better vagal tone is linked to better sleep, lower stress, less pain, and more stable mood.

Against this background, a gentle, non‑invasive technology has entered the field of women’s health: transcutaneous auricular vagus nerve stimulation (taVNS). In simple terms, it stimulates the vagus nerve through the skin of the ear. In this article, we’ll explain in clear language how hormonal changes affect the nervous system, what role the vagus nerve plays, and how taVNS may support women through different hormonal stages.

Why hormonal shifts affect sleep, mood, stress, and pain

During the menstrual cycle, estrogen and progesterone rise and fall across different phases. These hormones do far more than act on the uterus and ovaries—they also affect the brain, blood vessels, and neural circuits that control heart rate, blood pressure, mood, and pain perception.

A 2025 review in NeuroSci looked specifically at how the menstrual cycle influences the autonomic nervous system. The authors examined indicators like heart rate variability (HRV, a marker of vagal activity), baroreflex sensitivity (how well the body stabilizes blood pressure), and sympathetic nerve activity. The patterns they found match what many women feel in real life: certain phases are associated with more fatigue, irritability, poor sleep, and increased sensitivity to pain.

In simple terms:

Around menstruation, when both estrogen and progesterone are low, the body tends to drift into a “stress‑like” mode. The sympathetic system becomes more active, the vagus nerve is relatively less engaged, heart rate may be slightly higher, and the body feels more tense. Many women experience lower mood, more anxiety, and greater sensitivity to pain in this phase. This is why you may feel more “fragile” or on edge around your period—it’s not you overreacting; your nervous system is literally in a different physiological state.

Around ovulation, when estrogen rises, some studies suggest vagal activity improves and many women feel more emotionally stable, more energetic, and clearer in their thinking. In the luteal (pre‑menstrual) phase, progesterone rises again and is linked in some research to increased sympathetic drive and reduced vagal regulation. For some women, this shift contributes to PMS or PMDD: irritability, depressed mood, anxiety, insomnia, or feeling easily overwhelmed, often have an autonomic component behind them.

Menopause tells a similar story, but stretched over years instead of days. A 2025 review in Autonomic Neuroscience highlighted that cardiovascular risk in women rises sharply around menopause, and a major reason is the loss of estrogen’s protective influence on the autonomic and vascular systems. With age, sympathetic activity naturally increases, but in women around midlife this rise can be steeper. When estrogen levels fall:

  • Sympathetic “gas pedal” activity tends to increase
  • Vagal “brake” on heart rate and blood pressure becomes weaker
  • Blood vessels become stiffer and less responsive

Common menopausal symptoms like hot flashes, night sweats, poor sleep, palpitations, and mood swings are all closely tied to these autonomic shifts.

You can think of it this way: whether it’s the monthly menstrual cycle or the menopausal transition, hormones are constantly turning the dials on the autonomic nervous system. When the sympathetic system stays “on” too much and the vagus nerve is underactive, women are more likely to feel anxious, in pain, exhausted, sleepless, and physically unsteady.


The vagus nerve: the master regulator of body–mind balance

The vagus nerve is the main parasympathetic nerve in the body. It runs from the brainstem down to the heart, lungs, and digestive organs. It’s like a high‑speed communication highway: it sends information from the organs to the brain and carries “rest, heal, and calm down” messages from the brain back to the body.

For women, the vagus nerve is deeply involved in several key areas:

First, stress and cortisol regulation. The better your vagal tone, the more resilient you tend to be under stress. You can recover more quickly after something stressful happens. When vagal tone is low, it’s easy to feel stuck in a “constant fight‑or‑flight mode”: always tense, easily overwhelmed, and unable to fully relax.

Second, pain and inflammation. The vagus nerve helps control inflammatory responses through what’s called the cholinergic anti‑inflammatory pathway. Inflammation, pain, and mood are often tightly connected. Many people with chronic pain also struggle with anxiety and depression. Research suggests that supporting vagus nerve activity can help improve pain and emotional distress in certain conditions.

Third, heart rate and blood pressure. The vagus nerve is the body’s natural brake: it slows the heart rate and helps keep blood pressure variability within a healthy range. This is especially important around menopause, when sympathetic activity tends to rise; without enough vagal braking, palpitations and high blood pressure can become more common.

Finally, mood and cognition. Vagal signals influence brain areas involved in emotional regulation, attention, and decision‑making. Better vagal function is often associated with stronger self‑regulation and emotional stability.

So when women experience mood swings, worsening pain, poor sleep, or heightened stress around “that time of the month,” postpartum, or during peri‑ and post‑menopause, what’s happening under the surface is often a shift toward sympathetic dominance and reduced vagal regulation—the autonomic system is out of balance.


What is taVNS, and how might it help?

Transcutaneous auricular vagus nerve stimulation (taVNS) sounds technical, but the principle is quite straightforward. Certain parts of the outer ear—such as the cymba concha and cavum concha—are innervated by a branch of the vagus nerve. By placing small electrodes on these spots and delivering very mild, safe electrical pulses, we can gently activate the vagus nerve through the skin.

Unlike traditional implanted VNS, taVNS:

  • Requires no surgery
  • Is applied externally on the ear
  • Can be used at home or in daily life
  • Is non‑invasive and designed to be comfortable

You can think of it as a “gentle nerve therapy through the ear” that you can integrate into your routine.

In women’s health, the clearest and most direct evidence so far comes from studies on primary dysmenorrhea (menstrual pain without structural disease like fibroids or endometriosis).

A randomized controlled trial published in Neuromodulation in 2025 recruited 34 women with primary dysmenorrhea. They were randomly assigned to either real taVNS or sham stimulation (which looked the same but did not actually stimulate the vagus nerve). The treatment protocol was simple: starting 5 days before the expected second menstrual period, the women used taVNS once a day for 5 consecutive days. Electrodes were placed on the tragus and nearby ear areas, with stimulation at 10 Hz for 5 minutes at a comfortable intensity.

The results were striking. Compared with the sham group, women using taVNS had significantly less pain during their next period. Their pain ratings went down, and their tolerance to pressure pain improved. Importantly, it wasn’t just the pain that changed: their menstrual symptom questionnaires showed fewer daily life disruptions, their anxiety scores dropped, and they even did better on a 6‑minute walking test, reflecting better physical functioning and overall state. This suggests that taVNS is not simply “numbing the pain,” but helping the nervous system regulate pain and emotional responses more effectively.

An earlier pilot study in Brain Stimulation also found that 10 days of taVNS applied to the left ear reduced both the duration and intensity of menstrual pain, along with overall menstrual symptom burden.

Taken together, these studies point in the same direction: gentle vagus nerve stimulation through the ear can reduce menstrual pain, lower pain sensitivity, and ease the anxiety and emotional toll that often come with painful periods.

Although the uploaded articles focus mainly on dysmenorrhea and the autonomic aspects of menopause, other research has explored taVNS in migraine, depression, certain abdominal pain conditions, and sleep problems, with encouraging results. For women in midlife and beyond, there is a strong theoretical basis for using taVNS to support:

  • Distress related to hot flashes and night sweats
  • Menopause‑related anxiety, stress, and autonomic “over‑activation”
  • Heart rate and blood pressure regulation as an adjunct to medical care

In other words, taVNS is not a magic cure for one specific disease, but a way to support vagus nerve function and autonomic balance—helping the body maintain inner stability across changing hormonal landscapes.


Our vision: a “pocket‑sized comfort tool” for hormonal transitions

We hope taVNS can become more than just a neuromodulation device. Our vision is for it to be a supportive tool women can lean on across different life stages.

For many, “those days” mean pain, low mood, reduced productivity, and a tendency to withdraw from social life. The premenstrual days can bring irritability and anxiety. Perimenopause can feel like a long rollercoaster of emotional and physical upheaval. Our wish is that you don’t have to simply endure all of this without support.

Imagine using taVNS as a small ritual of self‑care: in the days before your period, you take a few minutes for a session to gently prepare your nervous system. During painful days, you combine it with a hot water bottle, rest, and some deep breathing to help your body step back from constant sympathetic overdrive. On nights when premenstrual mood swings or anxiety keep you awake, a short taVNS session before bed, perhaps paired with meditation or calming music, becomes your way of pressing “pause”.

For women in menopause, taVNS could be a “pocket‑sized comfort tool” when hot flashes, night sweats, palpitations, or irritability flare up. Instead of feeling completely at the mercy of these symptoms, you have something practical to help you gradually regain a sense of control.

We also believe that beauty is not just about skin or appearance; it’s an inner sense of stability, safety, and vitality. When stress is lower, sleep is better, and pain no longer dominates your life, your entire presence changes. You don’t just look better—you genuinely feel better.

Our intention in developing taVNS technology is simple:

  • To be there when you need support—not only in hospitals, but in your everyday life.
  • To fit into the small pockets of time in your busy schedule and give you a moment of repair.
  • To quietly accompany you through each hormonal wave, helping you move more smoothly through every cycle and every big transition.

Of course, research on taVNS in different aspects of women’s health—especially around menopause—is still evolving. Safety and proper use are extremely important. taVNS does not replace medical diagnosis or treatment. Women with heart disease, implanted pacemakers, epilepsy, pregnancy, or other special conditions should consult a healthcare professional before use. But as scientific evidence grows, we are already seeing that gently supporting the vagus nerve can genuinely help many women navigate those “hormone‑heavy” times with more ease.

Our vision is straightforward:
As your body and life change, we want you to be able to meet each phase more calmly, live more comfortably, and truly—feel better, look better, and glow always.

Reference: 

Kızkın, Zeynep Yıldız, Rıdvan Yıldız, and Ali Veysel Özden. "Effects of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals with Primary Dysmenorrhea: A Randomized Controlled Trial." Neuromodulation: Technology at the Neural Interface (2025).

Lee, E. J., and M. L. Keller-Ross. "Menopause and its effects on autonomic regulation of blood pressure: Insights and perspectives." Autonomic Neuroscience (2025): 103295.

Roy, Sankanika, Elettra Agordati, and Thomas DW Wilcockson. "Autonomic nervous system, cognition, and emotional valence during different phases of the menstrual cycle—a narrative review." NeuroSci 6.3 (2025): 78.

Stokes, William H., et al. "Vasomotor symptoms of menopause, sympathetic activity, and blood pressure in postmenopausal females." American Journal of Physiology-Heart and Circulatory Physiology (2025).

Wang, Chenxi, et al. "Transcutaneous auricular vagus nerve stimulation for the treatment of primary dysmenorrhea: A pilot study." Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation 16.3 (2023): 695-697.

 

Related Posts

Vagus Nerve Stimulation for Rheumatoid Arthritis:What Research Shows About This Emerging Treatment

Vagus nerve stimulation for rheumatoid arthritis is no longer only a laboratory idea, but the answer depends on the device. In the United States,...
發表者 ZhangLi
Oct 29 2026

World Bipolar Day: How Vagus Nerve Stimulation May Support Better Mental Health

March 30 marks World Bipolar Day and also the birthday of Vincent van Gogh. This coincidence offers more than a symbolic moment. It invites us...
發表者 Dr. XIAOJane
Oct 27 2026

研究前沿|迷走神經刺激器植入後的大型語言模型縱向症狀追蹤

簡介 植入迷走神經刺激(VNS)裝置後,患者狀況隨時間的變化通常會記錄在臨床紀錄中。這些紀錄可能描述患者在個別就診時的癲癇發作、情緒或疼痛。然而,由於紀錄格式缺乏結構,若要系統性比較數年間的變化,會相當困難。 2026 年發表於 JAMIA Open 的一項研究,評估大型語言模型(LLM)是否能從臨床紀錄中擷取症狀和嚴重程度評分,以建立患者層級的縱向變化軌跡。研究的主要重點,是評估一種臨床資訊擷取方法的表現。由此產生的變化軌跡,也初步呈現了患者之間的差異。 背景 臨床紀錄的限制 臨床紀錄必須區分「明確記載為不存在的症狀」與「未被提及的症狀」。前者表示該次就診曾進行相關評估;後者則不提供任何有關症狀狀態的資訊。紀錄中也可能提到某項持續存在的症狀,但沒有足夠細節可以判定其嚴重程度。如果把所有這類紀錄都分類為症狀不存在,就會在縱向變化估計中引入錯誤。 標準化量表可以提供一致的症狀評估,但不一定會在每次例行就診時完成。因此,研究人員檢視了是否能從現有臨床紀錄中可靠地擷取症狀,並追蹤其隨時間的變化。在使用這些紀錄進行更詳細的縱向分析之前,這是必要的方法學步驟。 方法 症狀擷取與嚴重程度分類 研究人員建立了 5 個資料集,共包括 95 名患者和 1,427 份由人工標註的臨床紀錄。訓練資料主要來自與 COVID 相關的紀錄,並加入接受 VNS 或其他手術照護患者的額外紀錄。資料以患者為單位,分為訓練集(58...
發表者 Dr. XIAOJane
Oct 23 2026

SPARC 十年歷程與超過 3.5 億美元資助:從神經定位到精準迷走神經調節

簡介 心跳、胃腸蠕動與膀胱充盈,都受到自律神經系統調節。研究人員希望透過電刺激影響神經活動,為器官功能障礙開發新的介入方式。然而,要準確地將刺激導向與疾病相關的神經纖維,並產生可重複的器官反應,仍需要回答幾個具體問題。神經會投射到哪些位置?不同個體之間的差異有多大?刺激後哪些功能會改變?又要如何及時偵測刺激目標以外的影響? 2026 年,Bhavesh Patel 及其同事在 Bioelectronic Medicine 發表綜述,整理美國國立衛生研究院(NIH)Stimulating Peripheral Activity to Relieve Conditions(SPARC)計畫的主要成果。該計畫於 2015 年啟動,向近 100 個研究項目提供超過 3.5 億美元資助,並促成 500 多篇出版物。 這篇綜述說明,神經圖譜、科技工具與開放資源如何共同支持精準神經調節。文章也指出,將基礎研究轉化為臨床應用時,仍然存在許多挑戰。 精準神經調節的主要挑戰 迷走神經將大腦與多個內部器官連接起來,是生物電子醫學的重要目標。然而,單一神經內含有走向與功能不同的神經纖維,因此刺激可能同時影響目標器官與其他生理過程。電極放置位置、神經束組織方式與刺激參數,會共同決定哪些神經纖維被招募。...
發表者 Dr. XIAOJane
Oct 23 2026

迷走神經刺激療法中,TENS貼片該貼在哪裡?

TENS 貼片該貼在哪裡才能刺激迷走神經? 如果你正在找 TENS 貼片該貼在哪裡才能刺激迷走神經,直接的回答是:不要把一般 TENS 貼片貼在脖子前方或側面。頸部包含頸動脈竇與主要神經,未經規範的電刺激可能對它們造成危險影響。對於非侵入性迷走神經刺激,最常被討論的做法是耳部刺激,也稱為 taVNS(經皮耳部迷走神經刺激)。不過,標準方形 TENS 貼片並不適合耳朵——耳朵彎曲的解剖構造需要耳夾電極或專為耳朵設計的形式。相關的耳部區域包括耳屏、耳甲艇與耳甲腔。如果你想要更簡單、更可靠、不必自行摸索的日常流程,專為耳部穿戴設計的 taVNS 裝置,例如 ZenoWell Vita 或 ZenoWell Luna,可能比硬把標準 TENS 機改裝上去更好。 主要擺放區域:耳部迷走神經刺激 如果你的目標是刺激迷走神經——無論是透過 TENS 機、耳夾,還是專用裝置——最實用且最有實證支持的做法,就是耳部迷走神經刺激,也稱為 taVNS。...
發表者 Dr. XIAOJane
Oct 22 2026

研究前沿|隨機對照研究證實,經皮耳迷走神經刺激能有效減輕肩關節鏡手術後的反彈性疼痛

簡介 神經阻滯消退時的疼痛 肩關節鏡手術後,疼痛起初可能控制良好,但隨著神經阻滯消退,疼痛可能突然加劇。這種由輕微疼痛轉為劇烈疼痛的過程稱為反彈痛,可能干擾休息與術後恢復。在阻滯作用逐漸減弱時維持穩定鎮痛,仍是圍手術期疼痛管理的重要挑戰。 2026年9月15日,Jun Zhang及其同事在《Regional Anesthesia & Pain Medicine》發表一項隨機、假刺激對照試驗,研究經皮耳部迷走神經刺激(taVNS)是否能降低肩關節鏡手術後反彈痛的發生率。 研究納入120名患者,將taVNS與假刺激,和常規麻醉及鎮痛方案進行比較。手術後24小時內,taVNS組較少出現反彈痛,部分恢復及睡眠指標也有所改善。然而,平均疼痛分數的下降幅度很小,兩組鎮痛藥使用量的差異未達統計學顯著。 背景 反彈痛管理的缺口 單次肌間溝臂叢神經阻滯(ISB)是肩部手術常用的區域鎮痛技術。局部麻醉劑作用於神經周圍,可提供約12至24小時的鎮痛,但藥效消退時,手術部位的疼痛可能迅速出現。因此,評估鎮痛策略時應單獨關注反彈痛:單日平均疼痛分數可能無法充分反映這種急劇而短暫的變化。 連續神經周圍導管及輔助藥物有助於處理這個問題,但也會增加操作、管理或藥物相關負擔。taVNS透過貼於耳部皮膚的電極刺激迷走神經耳支,為研究輔助鎮痛提供另一途徑。其給予方式不同於植入式迷走神經刺激、經皮頸部刺激及針刺式耳部神經調節。 過去研究曾探討耳部神經刺激對術後疼痛的影響,但針對單次ISB後反彈痛的證據仍有限。本試驗事先將反彈痛指定為主要終點,並在既有多模式鎮痛基礎上測試taVNS的附加效果。 方法 隨機比較與刺激方案 這項單中心試驗在中國浙江省德清縣人民醫院進行。在接受篩查的142人中,120名符合條件且安排接受肩關節鏡手術的患者按1:1隨機分組,每組60人。所有患者均完成追蹤,並納入意向治療分析。患者、結果評估者及資料分析人員均保持盲法;負責施加刺激的人員知道分組。 兩組均接受全身麻醉、一次性超聲引導ISB,以及標準化靜脈布洛芬和患者自控舒芬太尼鎮痛。ISB使用15毫升0.5%羅哌卡因。taVNS施加於左側耳甲艇,頻率30 Hz、脈衝寬度250 μs,刺激30秒、休息30秒交替進行。強度逐步提高,直到患者感到明顯麻刺感,再降低至患者確認無感覺的程度。首次治療在術前等候區開始,拔管後轉入麻醉後照護單位前持續進行。術後第1及第2天早上各進行一次2小時治療。假刺激組接受相同的電極放置及感覺閾值測試,但治療期間裝置輸出設定為零。 主要結果是手術後24小時內反彈痛的發生率。研究人員使用0至10分數字評分量表(NRS),將反彈痛定義為阻滯消退後疼痛由≤3升至≥7,且至少上升4分。阻滯消退是根據疼痛變化推定,並未透過連續感覺檢查確認。次要結果包括術後6、12、24及48小時的疼痛與舒芬太尼累積用量、恢復品質、睡眠品質及不良事件。主要結果採用卡方檢驗分析,重複測量的次要結果採用混合效應模型。恢復及睡眠分數的時間點比較進行Bonferroni校正。樣本量按主要終點估算;次要結果分析屬探索性質。 結果 主要終點與效果量...
發表者 Dr. XIAOJane
Oct 13 2026

2026 世界心理健康日:主題與有意義的行動

2026 世界心理健康日為 10 月 10 日星期六。世界衛生組織(WHO)與 World Federation for Mental Health(WFMH)公布的官方主題是「Lived experiences heard: real voices, real change」[1], [2]。今年的倡議重點,是傾聽具有心理健康相關親身經驗的人,並讓他們真正參與影響自身生活的決策、服務與政策。 個人、職場與社區都可以透過實際支持、自願參與的對話、心理健康倡議活動,以及在活動日之後持續進行的行動來參與。真正有意義的參與不需要大型活動,也不一定需要預算。2026 世界心理健康日的核心,是把「提高關注」與「傾聽」轉化為真正的參與及長期支持。 2026 世界心理健康日的主題是什麼? 2026 世界心理健康日的官方主題是「Lived...
發表者 Dr. XIAOJane
Oct 10 2026

Research Frontiers|33 萬人睡眠數據顯示:健康睡眠模式與較低失智症風險相關

中年睡眠與大腦健康 中年時期的睡眠習慣,和十多年後的失智症風險有什麼關係?一項超過 33 萬人的研究,同時分析多項睡眠特徵,包括每天的睡眠時間、頻繁失眠與白天嗜睡,評估這些特徵和日後失智症之間的關聯。 這項研究由 Tao Wei、Jie Chang 與同事進行,並於 2025 年 9 月 30 日發表在 Alzheimer's Research & Therapy。研究使用 UK Biobank 資料,參與者在納入研究時年齡為 40 至...
發表者 Dr. XIAOJane
Oct 10 2026